Anika: Overview of Fourth Quarter Financial Results

Anika Therapeutics Reports Fourth Quarter Results

Anika Therapeutics Inc., based in Bedford, Massachusetts, announced a net profit of $292,000 for the fourth quarter, reversing a loss from the same period last year.

The company’s earnings amounted to $0.02 per share. When adjusted for stock-based compensation and discontinued operations, earnings reached $0.31 per share.

During the quarter, Anika generated $30.6 million in revenue.

For the full year, Anika reduced its net loss to $10.9 million, or $0.76 per share, with annual revenue totaling $112.8 million.

Looking ahead, the company anticipates its revenue for the upcoming year will fall between $114 million and $122.5 million.

Since the start of the year, Anika’s stock price has climbed 14%, though it remains down 38% over the past twelve months.